| 查看: 425 | 回复: 0 | |||
[交流]
表征多晶型的转变
|
| Many drugs are formulated as solids. Although convenient and compact, solid drug formulations can be problematic because the active pharmaceutical ingredient can exist in more than one thermodynamically or kinetically stable crystalline or amorphous form, and can interconvert between these forms during processing or storage. The ability of a compound to exist in different solid state forms (polymorphism) impacts the solubility, and thus the bioavailability, of the pharmaceutical. Interconversion from a more soluble to a less soluble form may occur during manufacture of the pure drug, during formulation processes, and after long-term storage, thereby changing the pharmaceutically-active properties of the final product. |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : 表征多晶形的转变.pdf
2016-07-04 16:19:44, 359.23 K
» 猜你喜欢
基金申报
已经有5人回复
-
基金委咋了？2026年的指南还没有出来？
已经有7人回复
-
国自然申请面上模板最新2026版出了吗？
已经有17人回复
-
纳米粒子粒径的测量
已经有8人回复
-
疑惑？
已经有5人回复
-
计算机、0854电子信息（085401-058412）调剂
已经有5人回复
-
Materials Today Chemistry审稿周期
已经有5人回复
-
溴的反应液脱色
已经有7人回复
-
推荐一本书
已经有12人回复
-
常年博士招收(双一流，工科)
已经有4人回复